Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00684099 · COMPLETED
Trial details
- NCT number
- NCT00684099
- Sponsor
- Hellenic Oncology Research Group
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2009-05-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.